Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Alterations of Gut Microbiome Accelerate Multiple Myeloma Progression By Increasing the Relative Abundances of Nitrogen Recycling Bacteria

Xingxing Jian, PhD, Yinghong Zhu, Jian Ouyang, Qian Lei, Jiliang Xia, PhD, Jingyu Zhang, Jiaojiao Guo, Jinuo Wang, MD, Jingchao Lin, Mingming Su, Yongjun Guan, Guancheng Li, PhD, Minghua Wu, PhD, Jian Li, MD, Juanjuan Xiang, PhD, Lu Xie, PhD, Lugui Qiu, MD PhD, Wei Jia, PhD, Wen Zhou, PhD

Blood (2019) 134 (Supplement_1): 688.

https://doi.org/10.1182/blood-2019-125051

Published: 2019

Journal Articles

Fecal Microbiota Transplantation As a Treatment of Severe Steroid-Resistant Acute and Chronic Graft Versus Host Disease. Spectrum of Responses and Complications

Jaroslaw Bilinski, MD PhD, Karol Lis, MD, Agnieszka Tomaszewska, MD PhD, Pawel Grzesiowski, MD PhD, Aleksandra Pechcinska, Tomasz Dzieciatkowski, Kazimierz Halaburda, MD PhD, Magdalena Tormanowska, MD PhD, Martyna Tyszka, MD, Krzysztof Mądry, MD PhD, Ewa Karakulska-Prystupiuk, MD PhD, Alicja Hoffman, Wieslaw W. Jedrzejczak, MD PhD, Grzegorz W Basak, MD PhD Professor

Blood (2019) 134 (Supplement_1): 5667.

https://doi.org/10.1182/blood-2019-127063

Published: 2019

Journal Articles

Efficacy of Fecal Microbiota Transplant in Hematological Cancers Patients with Recurrent Clostridioides Difficile Infection: A Systemic Review and Meta-Analysis

Raseen Tariq, MBBS, Fateeha Furqan, MD, Saad Jamshed, MD, Sahil Khanna, MBBS

Blood (2019) 134 (Supplement_1): 5870.

https://doi.org/10.1182/blood-2019-131431

Published: 2019

Journal Articles

The Odyssee Study: Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transfer (FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment: Results of a Prospective Multicenter Trial

Blood (2018) 132 (Supplement 1): 1444.

https://doi.org/10.1182/blood-2018-99-112825

Published: 2018

Journal Articles

Repeated Courses of Orally Administered Fecal Microbiota Transplantation for the Treatment of Steroid Resistant and Steroid Dependent Intestinal Acute Graft Vs. Host Disease: A Pilot Study (NCT 03214289)

Roni Shouval, MD PhD, Ilan Youngster, MD MSc, Mika Geva, MD, Adi Eshel, MSc, Ivetta Danylesko, MD, Avichai Shimoni, MD, Katia Beider, Joshua A Fein, Itai Sharon, PhD, Omry Koren, PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 2121.

https://doi.org/10.1182/blood-2018-99-110270

Published: 2018

Journal Articles

Syngeneic Fecal Microbiota Transplant Effectively Attenuated Graft-Versus-Host Disease after Bone Marrow Transplantation in Mice

Wei Huang, MD PhD, Amy Bush, BA, Nelson J. Chao, MDM.B.A, Benny J. Chen, MD, Anthony D. Sung, MD

Blood (2017) 130 (Supplement 1): 4435.

https://doi.org/10.1182/blood.V130.Suppl_1.4435.4435

Published: 2017

Journal Articles

Fecal Microbiota Transplantation As Safe and Successful Therapy for Intestinal Graft-Versus-Host Disease

Yannouck F van Lier, MD, Pieter F de Groot, MD, Erfan Nur, MD PhD, Sacha S Zeerleder, MD PhD, Max Nieuwdorp, MD PhD, Bianca Blom, PhD, Mette D Hazenberg, MD PhD

Blood (2017) 130 (Supplement 1): 1986.

https://doi.org/10.1182/blood.V130.Suppl_1.1986.1986

Published: 2017

Journal Articles

Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone-Marrow Transplantation in Mice

Anna Staffas, PhD MSc, Marina Burgos da Silva, PhD, Ann E. Slingerland, BS, Amina Lazrak, BS, Yusuke Shono, MD PhD, Benjamin H Durham, MD BS, Christoph K. Stein-Thoeringer, MD, Melissa Docampo, Hillary V. Jay, Sophia R. Lieberman, Odette M. Smith, BA, Eric G. Pamer, MD, Jonathan U. Peled, MD, Robert R. Jenq, MD, Marcel R.M. van den Brink, MD PhD

Blood (2017) 130 (Supplement 1): 1899.

https://doi.org/10.1182/blood.V130.Suppl_1.1899.1899

Published: 2017

Journal Articles

Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transplantation (auto-FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment (ODYSSEE study): First Results of a Prospective Multicenter Trial

Mohamad Mohty, MD PhD, Florent Malard, MDPhD, Evelyne D'Incan, MD, Xavier Thomas, MD, Christian Recher, MD PhD, Anne-Sophie Michallet, MD PhD, Pierre Peterlin, MD, Anne Vekhoff, Norbert Vey, Emilie Plantamura, Philippe Lehert, Joel Doré, Ollivier Legrand, MD PhD

Blood (2017) 130 (Supplement 1): 2624.

https://doi.org/10.1182/blood.V130.Suppl_1.2624.2624

Published: 2017

Journal Articles

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Mehrdad Hefazi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB, Mark R Litzow, MD, Darrell S Pardi, MD, Sahil Khanna, MBBS

Blood (2016) 128 (22): 3599.

https://doi.org/10.1182/blood.V128.22.3599.3599

Published: 2016

Journal Articles

Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut

Kazuhiko Kakihana, Yuki Fujioka, Wataru Suda, Yuho Najima, Go Kuwata, Satoshi Sasajima, Iyo Mimura, Hidetoshi Morita, Daisuke Sugiyama, Hiroyoshi Nishikawa, Masahira Hattori, Yutaro Hino, Shuntaro Ikegawa, Keita Yamamoto, Takashi Toya, Noriko Doki, Koichi Koizumi, Kenya Honda, Kazuteru Ohashi

Blood (2016) 128 (16): 2083–2088.

https://doi.org/10.1182/blood-2016-05-717652

Published: 2016

Includes: Supplemental data

Journal Articles

Fecal microbiota transplantation for aGVHD of the gut

Blood (2016) 128 (16): 2107.

https://doi.org/10.1182/blood-2016-09-738062

Published: 2016

Journal Articles

Targeting Neutrophil Aging and the Microbiota for the Treatment of Sickle Cell Disease

Dachuan Zhang, MS, Grace Chen, PhD, Deepa Manwani, MD, Arthur Mortha, PhD, Chunliang Xu, PhD, Jeremiah J. Faith, PhD, Robert D. Burk, MD, Yuya Kunisaki, MD PhD, Jung-Eun Jang, PhD, Christoph Scheiermann, PhD, Miriam Merad, MD PhD, Paul S. Frenette, MD

Blood (2015) 126 (23): 279.

https://doi.org/10.1182/blood.V126.23.279.279

Published: 2015

Journal Articles

The Comparison of Allogeneic Stem Cell Transplantation From Family-Mismatched/Haploidentical Donors with Unrelated Donors in Adults with High-Risk Acute Myeloid Leukemia,

Byung-Sik Cho, Heeje Kim, Jae-Ho Yoon, Seung-Hwan Shin, Seung-Ah Yahng, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, MD, PhD, Jong-Wook Lee, Woo-Sung Min, Chong-Won Park

Blood (2011) 118 (21): 4164.

https://doi.org/10.1182/blood.V118.21.4164.4164

Published: 2011

Journal Articles

High Rate of Engraftment and Low Regimen-Related Toxicity Using Fludarabine, Melphalan and Thiotepa Conditioning for Unrelated Donor Cord Blood Transplantation

Stefan O Ciurea, MD, Partow Kebriaei, MD, Issa F Khouri, MD, Muzaffar H. Qazilbash, MD, Roy B Jones, MD, Demetrios Petropoulos, MD, Laura L. Worth, MD, PhD, Amin M Alousi, MD, Chitra M Hosing, MD, Poliana Patah, MD, Pedro Cano, PhD, John McMannis, PhD, Sergio A Giralt, MD, Marcelo Fernandez-Vina, PhD, Richard E Champlin, MD, Elizabeth J. Shpall, MD, Marcos De Lima, MD

Blood (2008) 112 (11): 4414.

https://doi.org/10.1182/blood.V112.11.4414.4414

Published: 2008

Journal Articles

Sustained Engraftment Using Fludarabine, Melphalan and Thiotepa Conditioning for Haploidentical Stem Cell Transplantation.

Stefan O. Ciurea, MD, Suhail Qureshi, MD, Gabriela Rondon, MD, Susana Pesoa, PhD, Pedro Cano, MD, John McMannis, PhD, Sergio Giralt, MD, Marcos de Lima, MD, Marcelo Fernandez-Vina, PhD, Richard E. Champlin, MD, James Gajewski, MD

Blood (2007) 110 (11): 5081.

https://doi.org/10.1182/blood.V110.11.5081.5081

Published: 2007

NARROW

Alterations of Gut Microbiome Accelerate Multiple Myeloma Progression By Increasing the Relative Abundances of Nitrogen Recycling Bacteria

Fecal Microbiota Transplantation As a Treatment of Severe Steroid-Resistant Acute and Chronic Graft Versus Host Disease. Spectrum of Responses and Complications

Efficacy of Fecal Microbiota Transplant in Hematological Cancers Patients with Recurrent Clostridioides Difficile Infection: A Systemic Review and Meta-Analysis

The Odyssee Study: Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transfer (FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment: Results of a Prospective Multicenter Trial

Repeated Courses of Orally Administered Fecal Microbiota Transplantation for the Treatment of Steroid Resistant and Steroid Dependent Intestinal Acute Graft Vs. Host Disease: A Pilot Study (NCT 03214289)

Syngeneic Fecal Microbiota Transplant Effectively Attenuated Graft-Versus-Host Disease after Bone Marrow Transplantation in Mice

Fecal Microbiota Transplantation As Safe and Successful Therapy for Intestinal Graft-Versus-Host Disease

Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone-Marrow Transplantation in Mice

Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transplantation (auto-FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment (ODYSSEE study): First Results of a Prospective Multicenter Trial

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut

Fecal microbiota transplantation for aGVHD of the gut

Targeting Neutrophil Aging and the Microbiota for the Treatment of Sickle Cell Disease

The Comparison of Allogeneic Stem Cell Transplantation From Family-Mismatched/Haploidentical Donors with Unrelated Donors in Adults with High-Risk Acute Myeloid Leukemia,

High Rate of Engraftment and Low Regimen-Related Toxicity Using Fludarabine, Melphalan and Thiotepa Conditioning for Unrelated Donor Cord Blood Transplantation

Sustained Engraftment Using Fludarabine, Melphalan and Thiotepa Conditioning for Haploidentical Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only